Open access peer-reviewed Edited Volume

Melanoma - Standard of Care, Challenges, and Updates in Clinical Research

Sonia Maciá

Highlight Therapeutics

A researcher working on clinical development to bring up new treatments to patients with. melanoma. After working as Medical Director at ICON Plc, she joined Highlight Therapeutics to work on clinical development. Dr. Maciá has submitted more than forty abstracts to international congresses, published more than thirty papers in peer-reviewed journals, and authored six book chapters.


Epidemiology Prognosis Immunotherapy Surgery Treatment Guidelines Treatment Selection Targeted Therapy Clinical Trials NCCN ESMO Challenges for Intratumoral Therapies Biomarkers

Register your interest in contributing to this book

Collaborate with our community and contribute your knowledge.

About the book

Prognosis has dramatically changed for melanoma patients within the last fifteen years, after incorporating immunotherapy and targeted therapies into the treatment arsenal. Melanoma is probably the tumor that has achieved the greatest benefit from immunotherapy, considerable improving responses, and survival. These novel therapies have also been gradually added to the adjuvant setting. In addition, clinical research is assessing new treatment combinations, treatments with different mechanisms of action, and different routes of administration, being melanoma one of the most suitable diseases to test intratumoral therapies. However, some important challenges and questions remain unanswered, as to which is the best treatment sequence depending on tumor burden and molecular features, or whether any biomarker (either immunohistochemistry, gene analysis, or imaging biomarkers) may have predictive value to select the most effective treatment.

This book will perform an overview on how the history of melanoma has changed and will review main treatment guidelines, focusing on main challenges we still face, to finish with a discussion regarding upcoming treatments and those which are still under clinical trials.

Publishing process

Book initiated and editor appointed

Date completed: February 24th 2022

Applications to edit the book are assessed and a suitable editor is selected, at which point the process begins.

Chapter proposals submitted and reviewed

Deadline Extended: Open for Submissions

Potential authors submit chapter proposals ready for review by the academic editor and our publishing review team.

Approved chapters written in full and submitted

Deadline for full chapters: June 26th 2022

Once approved by the academic editor and publishing review team, chapters are written and submitted according to pre-agreed parameters

Full chapters peer reviewed

Review results due: September 14th 2022

Full chapter manuscripts are screened for plagiarism and undergo a Main Editor Peer Review. Results are sent to authors within 30 days of submission, with suggestions for rounds of revisions.

Book compiled, published and promoted

Expected publication date: November 13th 2022

All chapters are copy-checked and typesetted before being published. IntechOpen regularly submits its books to major databases for evaluation and coverage, including the Clarivate Analytics Book Citation Index in the Web of ScienceTM Core Collection. Other discipline-specific databases are also targeted, such as Web of Science's BIOSIS Previews.

About the editor

Sonia Maciá

Highlight Therapeutics

Sonia Maciá, MD, is an ESMO-certified Medical Oncologist. She obtained a master’s degree in Pharmacoeconomy in 2018 from Universitat Pompeu Fabra Barcelona and a PhD in Lung Cancer from the Department of Clinical Medicine, University Miguel Hernández. Executive MBA by EAE/University of Barcelona. Dr. Maciá worked as a practicing Medical Oncologist for nine years and then decided to devote her career to clinical research. In 2012 she joined Pivotal SL, a European CRO, as Medical Manager, being thereafter promoted to Medical Director. After working as mMedical Director at ICON Plc, she joined Highlight Therapeutics to work on clinical development, providing medical support to clinical trials in solid tumors. Dr. Maciá has submitted more than forty abstracts to international congresses, published more than thirty papers in peer-reviewed journals, and authored six book chapters.

View profile

Book chapters authored 1

Books edited 1

Introducing your Author Service Manager

Ms. Ana Javor

As an Author Service Manager, my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors, and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact.

Ask a question

Book will be abstracted and indexed in